← Back to Search
Mast Cell Peptidases: Chameleons Of Innate Immunity And Host Defense.
N. Trivedi, G. Caughey
Published 2010 · Medicine, Biology
Save to my Library
Download PDFAnalyze on Scholarcy
Mast cells make and secrete an abundance of peptidases, which are stored in such large amounts in granules that they comprise a high fraction of all cellular protein. Perhaps no other immune cell is so generously endowed with peptidases. For many years after the main peptidases were first described, they were best known as markers of degranulation, for they are released locally in response to mast cell stimulation and can be distributed systemically and detected in blood. The principal peptidases are tryptases, chymases, carboxypeptidase A3, and dipeptidylpeptidase I (cathepsin C). Numerous studies suggest that these enzymes are important and even critical for host defense and homeostasis. Endogenous and allergen or pathogen-associated targets have been identified. Belying the narrow notion of peptidases as proinflammatory, several of the peptidases limit inflammation and toxicity of endogenous peptides and venoms. The peptidases are interdependent, so that absence or inactivity of one enzyme can alter levels and activity of others. Mammalian mast cell peptidases--chymases and tryptases especially--vary remarkably in number, expression, biophysical properties, and specificity, perhaps because they hyper-evolved under pressure from the very pathogens they help to repel. Tryptase and chymase involvement in some pathologies stimulated development of therapeutic inhibitors for use in asthma, lung fibrosis, pulmonary hypertension, ulcerative colitis, and cardiovascular diseases. While animal studies support the potential for mast cell peptidase inhibitors to mitigate certain diseases, other studies, as in mice lacking selected peptidases, predict roles in defense against bacteria and parasites and that systemic inactivation may impair host defense.
This paper references
Dibasic inhibitors of human mast cell tryptase. Part 2: structure-activity relationships and requirements for potent activity.
K. Rice (2000)
Potent, small-molecule inhibitors of human mast cell tryptase. Antiasthmatic action of a dipeptide-based transition-state analogue containing a benzothiazole ketone.
M. J. Costanzo (2003)
Neurotensin increases mortality and mast cells reduce neurotensin levels in a mouse model of sepsis
A. Piliponsky (2008)
Guinea Pig Chymase Is Leucine-specific
G. Caughey (2008)
Serine protease cathepsin G regulates adhesion-dependent neutrophil effector functions by modulating integrin clustering.
S. Z. Raptis (2005)
Tryptase genetics and anaphylaxis.
G. Caughey (2006)
Granzyme-like sequences in bony fish shed light on the emergence of hematopoietic serine proteases during vertebrate evolution.
S. Wernersson (2006)
Mast cell dipeptidyl peptidase I mediates survival from sepsis.
J. Mallen-St. Clair (2004)
Cytokine Production by Skin-Derived Mast Cells: Endogenous Proteases Are Responsible for Degradation of Cytokines 1
W. Zhao (2005)
δ Tryptase Is Expressed in Multiple Human Tissues, and a Recombinant Form Has Proteolytic Activity1
H. Wang (2002)
Substance P and vasoactive intestinal peptide degradation by mast cell tryptase and chymase.
G. Caughey (1988)
Chimerism, point mutation, and truncation dramatically transformed mast cell delta-tryptases during primate evolution.
N. Trivedi (2008)
Analysis of human skin mast cell proteins by two-dimensional gel electrophoresis. Identification of tryptase as a sialylated glycoprotein.
R. Benyon (1993)
Mammalian tissue trypsin-like enzymes. Comparative reactivities of human skin tryptase, human lung tryptase, and bovine trypsin with peptide 4-nitroanilide and thioester substrates.
T. Tanaka (1983)
Cathepsin g is required for sustained inflammation and tissue injury after reperfusion of ischemic kidneys.
N. Shimoda (2007)
Design, synthesis and pharmacological evaluation of 3-benzylazetidine-2-one-based human chymase inhibitors.
Y. Aoyama (2001)
Mast Cell-restricted Tryptases: Structure and Function in Inflammation and Pathogen Defense*
H. McNeil (2007)
Impaired immunity and enhanced resistance to endotoxin in the absence of neutrophil elastase and cathepsin G.
J. Tkalcevic (2000)
Mastin is a gelatinolytic mast cell peptidase resembling a mini-proteasome.
W. Raymond (2005)
Mouse Chromosome 17A3.3 Contains 13 Genes That Encode Functional Tryptic-like Serine Proteases with Distinct Tissue and Cell Expression Patterns*
G. W. Wong (2004)
Degradation of airway neuropeptides by human lung tryptase.
E. Tam (1990)
Structure of human pro-chymase: a model for the activating transition of granule-associated proteases.
K. K. Reiling (2003)
Protease-activated receptor 2 mediates the proinflammatory effects of synovial mast cells.
H. Palmer (2007)
Tryptase haplotype in mastocytosis: relationship to disease variant and diagnostic utility of total tryptase levels.
C. Akin (2007)
Bis(5-amidino-2-benzimidazolyl)methane and related amidines are potent, reversible inhibitors of mast cell tryptases.
G. Caughey (1993)
Tryptase Inhibition Blocks Airway Inflammation in a Mouse Asthma Model1
S. Oh (2002)
Cloning and Molecular Modeling of Duodenase with Respect to Evolution of Substrate Specificity within Mammalian Serine Proteases That Have Lost a Conserved Active-Site Disulfide Bond
T. S. Zamolodchikova (2005)
Human lung tryptase. Purification and characterization.
T. Smith (1984)
Mast Cell Cathepsins C and S Control Levels of Carboxypeptidase A and the Chymase, Mouse Mast Cell Protease 5
F. Henningsson (2003)
Lys40 but not Arg143 influences selectivity of angiotensin conversion by human α-chymase
D. Muilenburg (2002)
Delayed Expulsion of the Nematode Trichinella spiralisIn Mice Lacking the Mucosal Mast Cell–Specific Granule Chymase, Mouse Mast Cell Protease-1
P. Knight (2000)
Mast Cell IL-6 Improves Survival from Klebsiella Pneumonia and Sepsis by Enhancing Neutrophil Killing1
Rachel E. Sutherland (2008)
α2-Macroglobulin Capture Allows Detection of Mast Cell Chymase in Serum and Creates a Reservoir of Angiotensin II-Generating Activity1
W. Raymond (2009)
Our perception of the mast cell from Paul Ehrlich to now
M. Beaven (2009)
Induction of a selective and persistent extravasation of neutrophils into the peritoneal cavity by tryptase mouse mast cell protease 6.
C. Huang (1998)
Mouse prostasin gene structure, promoter analysis, and restricted expression in lung and kidney.
G. M. Verghese (2004)
Molecular mechanism of mast cell–mediated innate defense against endothelin and snake venom sarafotoxin
L. Schneider (2007)
Mast Cell Protease 5 Mediates Ischemia-Reperfusion Injury of Mouse Skeletal Muscle1
J. P. Abonia (2005)
Mouse Mast Cell Tryptase mMCP-6 Is a Critical Link between Adaptive and Innate Immunity in the Chronic Phase of Trichinella spiralis Infection1
Kichul Shin (2008)
Mast cell tryptase potentiates histamine-induced contraction in human sensitized bronchus.
P. Johnson (1997)
Prostasin regulates epithelial monolayer function: cell-specific Gpld1-mediated secretion and functional role for GPI anchor.
G. M. Verghese (2006)
Human mast cell carboxypeptidase. Selective localization to MCTC cells.
A. Irani (1991)
Chymase and tryptase in dog mastocytoma cells: asynchronous expression as revealed by enzyme cytochemical staining.
G. Caughey (1988)
Discovery of potent, selective, orally active, nonpeptide inhibitors of human mast cell chymase.
M. N. Greco (2007)
AN ENZYME IN MAST CELLS WITH PROPERTIES LIKE CHYMOTRYPSIN
E. Benditt (1959)
Alternate mRNA Splicing in Multiple Human Tryptase Genes Is Predicted to Regulate Tetramer Formation*
N. Jackson (2008)
The Chymase, Mouse Mast Cell Protease 4, Constitutes the Major Chymotrypsin-like Activity in Peritoneum and Ear Tissue. A Role for Mouse Mast Cell Protease 4 in Thrombin Regulation and Fibronectin Turnover
E. Tchougounova (2003)
Inhibition of mast cell tryptase by inhaled APC 366 attenuates allergen-induced late-phase airway obstruction in asthma.
M. T. Krishna (2001)
Treatment of mildly to moderately active ulcerative colitis with a tryptase inhibitor (APC 2059): an open‐label pilot study
W. Tremaine (2002)
Detection and partial characterization of a human mast cell carboxypeptidase.
Sanford M. Goldstein (1987)
Mast Cell and Neutrophil Peptidases Attack an Inactivation Segment in Hepatocyte Growth Factor to Generate NK4-like Antagonists*
W. Raymond (2006)
Mast Cells: A Cellular Link Between Autoantibodies and Inflammatory Arthritis
D. M. Lee (2002)
The human mast cell chymase gene (CMA1): mapping to the cathepsin G/granzyme gene cluster and lineage-restricted expression.
G. Caughey (1993)
Albumin Is a Substrate of Human Chymase
W. Raymond (2003)
Dipeptidyl Peptidase I Is Essential for Activation of Mast Cell Chymases, but Not Tryptases, in Mice*
P. Wolters (2001)
The Mast Cell-restricted Tryptase mMCP-6 Has a Critical Immunoprotective Role in Bacterial Infections*
S. M. Thakurdas (2007)
A novel heparin-dependent processing pathway for human tryptase. Autocatalysis followed by activation with dipeptidyl peptidase I.
K. Sakai (1996)
Articular mastocytosis in rheumatoid arthritis.
A. Crisp (1984)
Cloning of cDNAs that encode human mast cell carboxypeptidase A, and comparison of the protein with mouse mast cell carboxypeptidase A and rat pancreatic carboxypeptidases.
D. Reynolds (1989)
Structural Basis for Elastolytic Substrate Specificity in Rodent α-Chymases*
J. Kervinen (2008)
Mast cell tryptases and chymases in inflammation and host defense
G. Caughey (2007)
Tryptase from human pulmonary mast cells. Purification and characterization.
L. Schwartz (1981)
Genetic insights into mast cell chymase and tryptase function
G. Caughey (2004)
Inhibition of allergen-induced pulmonary responses by the selective tryptase inhibitor 1,5-bis-[4-[(3-carbamimidoyl-benzenesulfonylamino)-methyl]-phenoxy]-pen tane (AMG-126737).
C. D. Wright (1999)
Distribution of chymase-containing mast cells in human bronchi.
R. Matin (1992)
Mast Cell Tissue Inhibitor of Metalloproteinase-1 Is Cleaved and Inactivated Extracellularly by α-Chymase1
B. Frank (2001)
Protease inhibitors potentiate smooth muscle relaxation induced by vasoactive intestinal peptide in isolated human bronchi.
E. Tam (1990)
Angiotensin II generation by mast cell α- and β-chymases
G. Caughey (2000)
Rapid lineage-specific diversification of the mast cell chymase locus during mammalian evolution
Maike Gallwitz (2006)
Evaluation of human peripheral blood leukocytes for mast cell tryptase.
M. Castells (1987)
Extended Substrate Specificity of Rat Mast Cell Protease 5, a Rodent α-Chymase with Elastase-like Primary Specificity*
U. Karlson (2003)
A specific chymase inhibitor, NK3201, suppresses bleomycin-induced pulmonary fibrosis in hamsters.
Masato Sakaguchi (2004)
Purification and characterization of mouse mast cell proteinase‐2 and the differential expression and release of mouse mast cell proteinase‐1 and ‐2 in vivo
A. Pemberton (2003)
Inhaled tryptase causes bronchoconstriction in sheep via histamine release.
J. Molinari (1996)
Mast cell tryptase is a mitogen for epithelial cells. Stimulation of IL-8 production and intercellular adhesion molecule-1 expression.
J. Cairns (1996)
Pathological roles of angiotensin II produced by mast cell chymase and the effects of chymase inhibition in animal models.
M. Miyazaki (2006)
Mast-cell infiltration of airway smooth muscle in asthma.
C. Brightling (2002)
Inhibitors of Tryptase as Mast Cell-Stabilizing Agents in the Human Airways: Effects of Tryptase and Other Agonists of Proteinase-Activated Receptor 2 on Histamine Release
S. He (2004)
Mutations of the cathepsin C gene are responsible for Papillon-Lefèvre syndrome
T. Hart (1999)
A Kazal-type inhibitor of human mast cell tryptase: isolation from the medical leech Hirudo medicinalis, characterization, and sequence analysis.
C. Sommerhoff (1994)
Protease-activated receptor 2, dipeptidyl peptidase I, and proteases mediate Clostridium difficile toxin A enteritis.
G. Cottrell (2007)
Genetic deficiency of human mast cell a‐tryptase
D. Soto (2002)
CHLOROACYL ESTERS AS HISTOCHEMICAL SUBSTRATES
G. Gomori (1953)
Biology of mast cell tryptase
J. Hallgren (2006)
Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids
P. Woodruff (2007)
Structure and Activity of Human Pancreasin, a Novel Tryptic Serine Peptidase Expressed Primarily by the Pancreas*
V. Bhagwandin (2003)
Structure of human dipeptidyl peptidase I (cathepsin C): exclusion domain added to an endopeptidase framework creates the machine for activation of granular serine proteases
D. Turk (2001)
Human Tryptases α and β/II Are Functionally Distinct Due, in Part, to a Single Amino Acid Difference in One of the Surface Loops That Forms the Substrate-binding Cleft*
C. Huang (1999)
A Key Role for Mast Cell Chymase in the Activation of Pro-matrix Metalloprotease-9 and Pro-matrix Metalloprotease-2*
E. Tchougounova (2005)
Mast cell tryptase regulates rat colonic myocytes through proteinase-activated receptor 2.
C. Corvera (1997)
Dog mastocytoma tryptase: affinity purification, characterization, and amino-terminal sequence.
G. Caughey (1987)
Relationship of small airway chymase-positive mast cells and lung function in severe asthma.
S. Balzar (2005)
Synthesis and SAR of 4-carboxy-2-azetidinone mechanism-based tryptase inhibitors.
James C. Sutton (2002)
Mast Cell α-Chymase Reduces IgE Recognition of Birch Pollen Profilin by Cleaving Antibody-Binding Epitopes1
Matthew B Mellon (2002)
Conditional and targeted overexpression of vascular chymase causes hypertension in transgenic mice
H. Ju (2001)
Tryptase inhibitors block allergen-induced airway and inflammatory responses in allergic sheep.
J. Clark (1995)
Characterization of Human γ-Tryptases, Novel Members of the Chromosome 16p Mast Cell Tryptase and Prostasin Gene Families1
G. Caughey (2000)
Dog Mast Cell α-Chymase Activates Progelatinase B by Cleaving the Phe88-Gln89 and Phe91-Glu92 Bonds of the Catalytic Domain*
K. Fang (1997)
Localization of pathology in asthma
A. James (2009)
Expansion of the mast cell chymase locus over the past 200 million years of mammalian evolution
Maike Gallwitz (2006)
Expression and function of proteinase-activated receptor 2 in human bronchial smooth muscle.
F. Schmidlin (2001)
Evaluation of the Substrate Specificity of Human Mast Cell Tryptase βI and Demonstration of Its Importance in Bacterial Infections of the Lung*
C. Huang (2001)
A genomic analysis of rat proteases and protease inhibitors.
X. S. Puente (2004)
Critical protective role of mast cells in a model of acute septic peritonitis
B. Echtenacher (1996)
A Novel, Potent Dual Inhibitor of the Leukocyte Proteases Cathepsin G and Chymase
L. de Garavilla (2005)
Mast cell tryptase causes airway smooth muscle hyperresponsiveness in dogs.
K. Sekizawa (1989)
Non-peptidic inhibitors of human chymase. Synthesis, structure-activity relationships, and pharmacokinetic profiles of a series of 5-amino-6-oxo-1,6-dihydropyrimidine-containing trifluoromethyl ketones.
F. Akahoshi (2001)
Basophils preferentially express mouse mast cell protease 11 among the mast cell tryptase family in contrast to mast cells
T. Ugajin (2009)
Detection of MCT and MCTC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chymase antibodies.
A. Irani (1989)
Papillon-Lefèvre Syndrome: Correlating the Molecular, Cellular, and Clinical Consequences of Cathepsin C/Dipeptidyl Peptidase I Deficiency in Humans1
C. Pham (2004)
Specificity of human cathepsin G.
J. Polanowska (1998)
Covalent structure of a group-specific protease from rat small intestine. Appendix: crystallographic data for a group specific protease from rat intestine.
R. Woodbury (1978)
Mast cell tryptase and chymase reverse airway smooth muscle relaxation induced by vasoactive intestinal peptide in the ferret.
G. Franconi (1989)
Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis.
April M Adkison (2002)
Mast Cells Can Enhance Resistance to Snake and Honeybee Venoms
M. Metz (2006)
Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis.
L. Schwartz (1987)
Mast cells promote homeostasis by limiting endothelin-1-induced toxicity
M. Maurer (2004)
Neutrophil elastase and cathepsin G stimulate secretion from cultured bovine airway gland serous cells.
C. Sommerhoff (1990)
Strain-specific and tissue-specific expression of mouse mast cell secretory granule proteases.
R. Stevens (1994)
Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α
Ravi Malaviya (1996)
Mast cells contribute to initiation of autoantibody-mediated arthritis via IL-1
P. Nigrovic (2007)
Novel site-specific mast cell subpopulations in the human lung
C. Andersson (2009)
Human chymase inhibitors based on the 1,2,5-thiadiazolidin-3-one 1,1 dioxide scaffold.
W. Groutas (1999)
Regulated Expression, Processing, and Secretion of Dog Mast Cell Dipeptidyl Peptidase I*
P. Wolters (1998)
Human β-tryptase is a ring-like tetramer with active sites facing a central pore
P. Pereira (1998)
Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis.
L. Coussens (1999)
A Pulmonary Perspective on GASPIDs: Granule-Associated Serine Peptidases of Immune Defense.
G. Caughey (2006)
Human subjects are protected from mast cell tryptase deficiency despite frequent inheritance of loss-of-function mutations.
N. Trivedi (2009)
New developments in the genetics and activation of mast cell proteases.
G. Caughey (2002)
Mast Cell α and β Tryptases Changed Rapidly during Primate Speciation and Evolved from γ-Like Transmembrane Peptidases in Ancestral Vertebrates1
N. Trivedi (2007)
Tryptase, the dominant secretory granular protein in human mast cells, is a potent mitogen for cultured dog tracheal smooth muscle cells.
James K. Brown (1995)
Proteinase-Activated Receptor-2 Mediates Itch: A Novel Pathway for Pruritus in Human Skin
M. Steinhoff (2003)
Electron and light microscopical observations and serological findings in rheumatoid arthritis.
A. E. Helder (1973)
Deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice
Jian Liu (2009)
X-ray Structures of Free and Leupeptin-complexed Human αI-Tryptase Mutants: Indication for an α→β-Tryptase Transition
K. Rohr (2006)
Protease composition of exocytosed human skin mast cell protease-proteoglycan complexes. Tryptase resides in a complex distinct from chymase and carboxypeptidase.
Sanford M. Goldstein (1992)
The mouse mast cell-restricted tetramer-forming tryptases mouse mast cell protease 6 and mouse mast cell protease 7 are critical mediators in inflammatory arthritis.
H. McNeil (2008)
Potent induction of a neutrophil and eosinophil-rich infiltrate in vivo by human mast cell tryptase: selective enhancement of eosinophil recruitment by histamine.
S. He (1997)
Dual inhibition of cathepsin G and chymase is effective in animal models of pulmonary inflammation.
B. Maryanoff (2010)
PROTEOLYTIC ENZYMES OF MAST CELLS *
D. Lagunoff (1963)
c‐Kit immunophenotyping and metalloproteinase expression profiles of mast cells in interstitial lung diseases
S. T. Edwards (2005)
Characterization of Genes Encoding Known and Novel Human Mast Cell Tryptases on Chromosome 16p13.3*
M. Pallaoro (1999)
The 1.8 A crystal structure of human cathepsin G in complex with Suc‐Val‐Pro‐PheP‐(OPh)2: a Janus‐faced proteinase with two opposite specificities.
P. Hof (1996)
Rapid conversion of angiotensin I to angiotensin II by neutrophil and mast cell proteinases.
C. Reilly (1982)
Cooperation between Mast Cell Carboxypeptidase A and the Chymase Mouse Mast Cell Protease 4 in the Formation and Degradation of Angiotensin II*
A. Lundequist (2004)
Identification of a cathepsin G-like proteinase in the MCTC type of human mast cell.
N. Schechter (1990)
The mast cell in early rat adjuvant arthritis.
A. Gryfe (1971)
Mast cell tryptase is a mitogen for cultured fibroblasts.
S. J. Ruoss (1991)
Human and mouse proteases: a comparative genomic approach
X. S. Puente (2003)
Extended substrate specificity of opossum chymase--implications for the origin of mast cell chymases.
J. Reimer (2008)
Dipeptidyl peptidase I cleaves matrix-associated proteins and is expressed mainly by mast cells in normal dog airways.
P. Wolters (2000)
Molecular cloning of dog mast cell tryptase and a related protease: structural evidence of a unique mode of serine protease activation.
P. Vanderslice (1989)
Mammalian chymotrypsin-like enzymes. Comparative reactivities of rat mast cell proteases, human and dog skin chymases, and human cathepsin G with peptide 4-nitroanilide substrates and with peptide chloromethyl ketone and sulfonyl fluoride inhibitors.
J. Powers (1985)
This paper is referenced by
The Effect of Bifid Triple Viable on Immune Function of Patients with Ulcerative Colitis
G. Li (2012)
Sentinel Role of Mast Cells in Innate Immunity
Zhenping Wang (2011)
The Absence of Tryptase Mcpt6 Causes Elevated Cellular Stress in Response to Modulation of the Histone Acetylation Status in Mast Cells
Sebastin Santosh Martin (2019)
The mast cell as a regulator of atherosclerotic plaque stability
Hanna M Heikkilä (2010)
Tryptase as a polyfunctional component of mast cells
D. Atiakshin (2018)
Mast Cells Contribute to Bleomycin-Induced Lung Inflammation and Injury in Mice through a Chymase/Mast Cell Protease 4–Dependent Mechanism
L. Reber (2014)
hrough a Chymase/Mast Cell Protease 4 Lung Inflammation and Injury in Mice t Mast Cells Contribute to Bleomycin-Induced
Nelly Frossard (2014)
The role of mast cells in atrial natriuretic peptide-induced cutaneous inflammation
O. H. Chai (2011)
Two decades before the mast.
Paul J Bryce (2010)
Human α-, β- and δ-Tryptases
N. Trivedi (2013)
Nonallergic Asthma and Its Severity: Biomarkers for Its Discrimination in Peripheral Samples
S. Baos (2018)
Mast Cell Function
Elaine Zayas Marcelino da Silva (2014)
Interaktion und strukturelle Aspekte humaner IgE-Antikörper im Kontext der Allergie
S. Wolf (2015)
Mast cell chymase: an indispensable instrument in the pathological symphony of idiopathic pulmonary fibrosis?
D. Kosanovic (2013)
Potency variation of small-molecule chymase inhibitors across species.
J. Kervinen (2010)
Measurement of mast cell and basophil activation in vitro as means for investigation of drug hypersensitivity
D. Ludwig (2015)
Multifunctional Role of Chymase in Acute and Chronic Tissue Injury and Remodeling.
L. Dell'Italia (2018)
Origin, maturation and recruitment of mast cell precursors.
M. C. Jamur (2011)
Sphingosine-1-phosphate in mast cell-mediated allergic responses
Megan Price (2011)
Mast cell recruitment and activation as measures of cyathostomin burden
Ruth Clements (2015)
Effects of palmitoylethanolamide on release of mast cell peptidases and neurotrophic factors after spinal cord injury
E. Esposito (2011)
AAAAI Mast Cell Disorders Committee Work Group Report: Mast Cell Activation Syndrome (MCAS) Diagnosis and Management.
C. Weiler (2019)
Mast cell proteases as protective and inflammatory mediators.
G. Caughey (2011)
Discriminating between the activities of human cathepsin G and chymase using fluorogenic substrates
B. Korkmaz (2011)
Mast Cells and Tumours
D. Ribatti (2011)
An Allosteric Anti-tryptase Antibody for the Treatment of Mast Cell-Mediated Severe Asthma
H. R. Maun (2019)
Exploring gene expression changes in the amphioxus gill after poly(I:C) challenge using digital expression profiling
Q. Zhang (2017)
Histological Characterization of Mast Cell Chymase in Patients with Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease
D. Kosanovic (2014)
The history of mast cell and basophil research – some lessons learnt from the last century
U. Blank (2013)
The Effect of Particle Deposition on Immunological Response as Measured by Cytokine Production
Madhuri Singal (2015)
The αvβ6 integrin modulates airway hyperresponsiveness in mice by regulating intraepithelial mast cells.
K. Sugimoto (2012)
Mouse Tryptase Gene Expression is Coordinately Regulated by GATA1 and GATA2 in Bone Marrow-Derived Mast Cells
K. Ohneda (2019)See more